Skip to content
10-Q

Quarterly Report

VAXXINITY, INC.

0001562762-23-000224

← back to feed
Filed
May 9, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Diluted Q1 2023 · Mar 31, 2023 126.06M sh
Shares Diluted Q1 2023 · Mar 31, 2022 125.71M sh
Capex Q1 2023 · Mar 31, 2023 $172K
Capex Q1 2023 · Mar 31, 2022 $713K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$20.05M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$19.51M
Short Term Investments Q1 2023 · Mar 31, 2023 $44.99M
Short Term Investments Q1 2023 · Dec 31, 2022 $53.35M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $22.59M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $33.48M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $124.77M
Stockholders Equity Q1 2023 · Mar 31, 2023 $46.13M
Stockholders Equity Q1 2023 · Dec 31, 2022 $62.18M
Stockholders Equity Q1 2023 · Mar 31, 2022 $112.66M
Stockholders Equity Q1 2023 · Dec 31, 2021 $128.62M
Current Liabilities Q1 2023 · Mar 31, 2023 $26.47M
Current Liabilities Q1 2023 · Dec 31, 2022 $30.94M
Total Liabilities Q1 2023 · Mar 31, 2023 $39.4M
Total Liabilities Q1 2023 · Dec 31, 2022 $44.22M
Current Assets Q1 2023 · Mar 31, 2023 $73.43M
Current Assets Q1 2023 · Dec 31, 2022 $93.89M
Total Assets Q1 2023 · Mar 31, 2023 $85.53M
Total Assets Q1 2023 · Dec 31, 2022 $106.4M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.15
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.15
Eps Basic Q1 2023 · Mar 31, 2023 −$0.15
Eps Basic Q1 2023 · Mar 31, 2022 −$0.15
Sga Expense Q1 2023 · Mar 31, 2023 $7.38M
Sga Expense Q1 2023 · Mar 31, 2022 $6.69M
Rd Expense Q1 2023 · Mar 31, 2023 $11.42M
Rd Expense Q1 2023 · Mar 31, 2022 $11.48M
Net Income Q1 2023 · Mar 31, 2023 −$18.42M
Net Income Q1 2023 · Mar 31, 2022 −$18.26M
Operating Income Q1 2023 · Mar 31, 2023 −$18.81M
Operating Income Q1 2023 · Mar 31, 2022 −$18.16M